Of note, decorin alleviated skeletal muscle fibrosis and atrophy in D‐gal–induced aged mice and NOR‐10 cells by activating the ITGB1/Akt/mTOR signalling pathway, which suggests that decorin supplementation may be a potent therapeutic strategy to combat age‐associated sarcopenia. This evidence concerns the gene AKT1 and sarcopenia.